SHPAX
Saratoga Advantage Tr Health & Biotechnology Port Cl A
$25.70
Saratoga Advantage Tr Health & Biotechnology Port Cl A (SHPAX)
SHPAX is a mutual fund that focuses on investing in the health and biotechnology sectors. It is part of the Saratoga Advantage Trust and is classified as Class A. This fund aims to provide investors with long-term capital appreciation by investing in companies involved in the development, production, and distribution of healthcare products and services, as well as biotechnology research and development. With a diverse portfolio of companies in these industries, SHPAX offers investors the potential for growth and diversification in their investment portfolio.
SHPAX Mutual Fund Chart & Stats
$25.70
At close: 4:00 PM EST- Previous Close
- $25.70
- Total Liabilities
- $61.52K
- Holding Count
- 29
- Brand
- Saratoga Advantage Trust
- Total Assets
- 11.62M
- Shares Outstanding
- N/A
- 52-Week Range
- $20.50 - $27.46
SHPAX Mutual Fund News
SHPAX Mutual Fund Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| JAZZJazz Pharmaceuticals | 5.95% |
| AMGNAmgen Inc | 5.83% |
| MCKMcKesson Corporation | 5.29% |
| CAHCardinal Health | 5.14% |
| UTHRUnited Therapeutics Corp. | 5.12% |
| CORCencora, Inc. | 4.71% |
| REGNRegeneron Pharmaceuticals | 4.63% |
| EXELExelixis | 4.47% |
| JNJJohnson & Johnson | 4.19% |
| NVSNovartis AG | 4.13% |
| Total | 49.47% |
Recently Viewed
No data currently available






